Compare UI & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UI | IQV |
|---|---|---|
| Founded | 2003 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.8B | 36.4B |
| IPO Year | 2011 | 2013 |
| Metric | UI | IQV |
|---|---|---|
| Price | $562.20 | $225.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 15 |
| Target Price | ★ $587.50 | $236.93 |
| AVG Volume (30 Days) | 85.1K | ★ 1.3M |
| Earning Date | 02-06-2026 | 02-05-2026 |
| Dividend Yield | ★ 0.58% | N/A |
| EPS Growth | ★ 102.50 | N/A |
| EPS | ★ 13.07 | 7.30 |
| Revenue | $2,756,974,000.00 | ★ $15,904,000,000.00 |
| Revenue This Year | $15.29 | $6.15 |
| Revenue Next Year | $8.93 | $5.39 |
| P/E Ratio | $42.34 | ★ $30.86 |
| Revenue Growth | ★ 36.77 | 3.85 |
| 52 Week Low | $255.00 | $134.65 |
| 52 Week High | $803.60 | $234.30 |
| Indicator | UI | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 45.52 | 53.34 |
| Support Level | $553.34 | $225.49 |
| Resistance Level | $572.45 | $228.28 |
| Average True Range (ATR) | 15.42 | 3.55 |
| MACD | 2.50 | -0.09 |
| Stochastic Oscillator | 58.51 | 62.34 |
Ubiquiti Inc is a seller of equipment and provides the related software platforms through web stores. The group develops technology platforms for high-capacity distributed Internet access, unified information technology, and consumer electronics for professional, home, and personal use. Its solutions are: high-performance networking technology for enterprises, service providers, and consumers. target the enterprise and service provider markets through a community of service providers, distributors, value-added resellers, webstores, systems integrators, and corporate IT professionals, which it refers to as the Ubiquiti Community. It targets consumers through digital marketing, including through webstores, retail chains, and, to a lesser extent, the Ubiquiti Community.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.